Texas Doctor's DEA License Yanked Over Suspension Drama
Published Date: 3/27/2025
Notice
Summary
Dr. Willard J. Davis from Texas lost his DEA registration because his medical license was suspended, meaning he can’t legally handle controlled substances anymore. The DEA reviewed the case, agreed with the suspension, and officially revoked his registration. This means Dr. Davis must stop all controlled substance activities immediately, affecting his medical practice and any related income.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
DEA Registration Revoked for Dr. Davis
The DEA revoked Willard J. Davis, D.O.'s Certificate of Registration No. BD9134254, so he must stop all controlled-substance activities immediately. The revocation follows the suspension of his Texas medical license on May 16, 2024, and the Order is effective April 28, 2025, which will affect his medical practice and any related income.
Future DEA Applications Denied in Texas
The DEA also denied any pending applications by Willard J. Davis, D.O., to renew or modify his registration and denied any other pending application for additional registration in Texas. That denial accompanies the revocation and is effective April 28, 2025, restricting his ability to regain DEA authorization in Texas.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2025-05007, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
Starting December 31, 2025, veterans can get buprenorphine treatment and follow-up care through telemedicine, making it easier to access help for opioid use disorder without leaving home. This change affects veterans using VA health services and aims to improve treatment access while the government reviews feedback and policies. No new costs are mentioned, but the delay gives agencies time to ensure the rules work well.
2025-02793, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
The government is giving veterans easier access to buprenorphine treatment through telemedicine, letting them get care remotely. This change affects veterans using VA health services and aims to make treatment smoother and more convenient. The new rules were supposed to start February 18, 2025, but now they’ll kick in on March 21, 2025, while the government gathers public feedback.
2026-20749, Vladimir Romaniv, P.A.; Decision and Order
The DEA has officially suspended and is moving to revoke Vladimir Romaniv, P.A.'s registration because he gave multiple prescriptions without properly checking on a patient who was in jail. This affects Romaniv’s ability to prescribe controlled substances and signals serious legal trouble starting from late 2025. If you’re connected to his practice or rely on his prescriptions, expect changes and tighter controls soon.
2026-20750, L Krenk DBA Maui Clinic Pharmacy; Decision and Order
The DEA has officially revoked L Krenk DBA Maui Clinic Pharmacy’s registration because they broke important rules about where and how they handled controlled substances. This affects the pharmacy in Kahului, Hawaii, which can no longer legally dispense these drugs. The decision is final, and the pharmacy missed its chance to defend itself, so the revocation takes effect immediately, impacting their business and customers.
Previous / Next Documents
Previous: 2025-05165, Harvey Leslie, M.D.; Decision and Order
Dr. Harvey Leslie from Georgia lost his medical license earlier this year, so the DEA is officially taking away his permission to handle controlled substances. Since he didn’t ask for a hearing, the DEA’s decision is final, meaning he can no longer prescribe or manage these drugs. This change is immediate and affects Dr. Leslie’s ability to work with controlled medicines, with no money or appeals left on the table.
Next: 2025-05167, Notice of Intent To Decommission Flight Service Remote Communications Outlets (RCOs)
The FAA plans to shut down many old radio communication spots called Remote Communications Outlets (RCOs) used by pilots across the U.S. because almost no one uses them anymore—most pilots now use mobile tech instead. This change will save taxpayers millions and won’t affect flight safety. If you have thoughts, send your comments by May 27, 2025!